Bioqual (Bioqual) EBIT : $5.34 Mil (TTM As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual EBIT?

Bioqual's earnings before interest and taxes (EBIT) for the six months ended in May. 2018 was $5.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in May. 2018 was $5.34 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bioqual's annualized ROC % for the quarter that ended in May. 2018 was 27.50%. Bioqual's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2018 was 54.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Bioqual EBIT Historical Data

The historical data trend for Bioqual's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual EBIT Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

EBIT

Get a 7-Day Free Trial

1.59

0.68

6.56

5.34

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
EBIT	Get a 7-Day Free Trial										1.59	0.68	0.68	6.56	5.34

Competitive Comparison of Bioqual's EBIT

For the Diagnostics & Research subindustry, Bioqual's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioqual's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bioqual's EV-to-EBIT falls into.

Bioqual EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in May. 2018 was $5.34 Mil.

Bioqual (OTCPK:BIOQ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bioqual's annualized ROC % for the quarter that ended in May. 2018 is calculated as:

	ROC % (Q: May. 2018 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: May. 2017 )	+	Invested Capital (Q: May. 2018 ))	/ count )
=	5.273 * ( 1 - 30.72% )	/	( (12.231	+	14.34)	/ 2 )
=	3.6531344	/	13.2855
=	27.50 %

where

	Invested Capital		(Q: May. 2017 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	22.76	-	1.241	-	( 9.288	-	max(0, 3.1	-	17.901	+	9.288	))
=	12.231

	Invested Capital		(Q: May. 2018 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	26.305	-	1.804	-	( 10.161	-	max(0, 3.464	-	20.253	+	10.161	))
=	14.34

Note: The Operating Income data used here is one times the annual (May. 2018) data.

2. Joel Greenblatt's definition of Return on Capital:

Bioqual's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2018 is calculated as:

	ROC (Joel Greenblatt) %		(Q: May. 2018 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: May. 2017		Q: May. 2018
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	5.336	/	( ( (2.948 + max(5.752, 0))	+	(4.288 + max(6.45, 0)) )	/	2 )
=	5.336	/	( ( 8.7	+	10.738 )	/	2 )
=	5.336	/	9.719
=	54.90 %

where Working Capital is:

	Working Capital		(Q: May. 2017 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.276	+	0	+	0.259)	-	(1.241	+	0.209	+	1.333)
=	5.752

	Working Capital		(Q: May. 2018 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(9.265	+	0	+	0.399)	-	(1.804	+	0.365	+	1.045)
=	6.45

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (May. 2018) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bioqual's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: May. 2018 )
	=	5.336	/	0.000
	=	%

Bioqual EBIT Related Terms

Thank you for viewing the detailed overview of Bioqual's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » EBIT

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines